[Controlling gastrointestinal risks in Bechterew disease. Interview by Dr. med. Katrina Recker].
Schattenkirchner
M
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008134:Long-Term Care; D000077239:Meloxicam; D010003:Osteoarthritis / Q000188:drug therapy*; D010437:Peptic Ulcer / Q000139:chemically induced*; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D013843:Thiazines / Q000008:administration & dosage / Q000009:adverse effects*; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam